Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

[Some clarifications regarding botulinum toxin type A units. Reply].

Alonso-Navarro H, Jimenez-Jimenez FJ, Plaza-Nieto JF, Pilo-De la Fuente B, Navacerrada F, Arroyo-Solera M, Calleja M.

Rev Neurol. 2012 Mar 1;54(5):319. Spanish. No abstract available.

2.

[Some clarifications regarding botulinum toxin type A units].

Martín-Hernández J.

Rev Neurol. 2012 Feb 16;54(4):255. Spanish. No abstract available.

3.

Botulinum Toxin A in bruxers. One year experience.

Redaelli A.

Saudi Med J. 2011 Feb;32(2):156-8.

PMID:
21301762
4.

[Treatment of severe bruxism with botulinum toxin type A].

Alonso-Navarro H, Jiménez-Jiménez FJ, Plaza-Nieto JF, Pilo-De la Fuente B, Navacerrada F, Arroyo-Solera M, Calleja M.

Rev Neurol. 2011 Jul 16;53(2):73-6. Spanish.

5.

Bruxism secondary to brain injury treated with botulinum toxin-A: a case report.

El Maaytah M, Jerjes W, Upile T, Swinson B, Hopper C, Ayliffe P.

Head Face Med. 2006 Nov 23;2:41.

6.

Botulinum toxin for trigeminal neuralgia--do we have the evidence?

Zakrzewska JM.

Cephalalgia. 2012 Nov;32(15):1154-5; author reply 1156-7. doi: 10.1177/0333102412459577. Epub 2012 Sep 18. No abstract available.

PMID:
22990690
7.

Botulinum toxin injection for bruxism associated with brain injury: case report.

Kesikburun S, Alaca R, Aras B, Tuğcu I, Tan AK.

J Rehabil Res Dev. 2014;51(4):661-4. doi: 10.1682/JRRD.2013.10.0218.

8.

Re: Botulinum A toxin as a treatment for overactive rectum with associated faecal incontinence.

Hotouras A, Chan CL.

Colorectal Dis. 2012 Jul;14(7):898-9. doi: 10.1111/j.1463-1318.2012.03064.x. No abstract available.

PMID:
22564854
9.

Botulinum toxin type A for neuropathic itch.

Wallengren J, Bartosik J.

Br J Dermatol. 2010 Aug;163(2):424-6. doi: 10.1111/j.1365-2133.2010.09783.x. Epub 2010 Mar 24. No abstract available.

PMID:
20346021
10.

Injection of botulinum toxin for treatment of chronic lateral epicondylitis.

Lin YC, Chen SM, Kuan TS, Hsieh PC, Guo YH, Lin IL, Jou IM.

Semin Arthritis Rheum. 2012 Jun;41(6):e1-2. doi: 10.1016/j.semarthrit.2011.12.004. Epub 2012 Feb 15. No abstract available.

PMID:
22341513
11.

Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A.

Saber M, Brassard D, Benohanian A.

Arch Dermatol. 2011 May;147(5):629-30. doi: 10.1001/archdermatol.2011.111. No abstract available.

PMID:
21576592
12.

Botulinum toxin-induced immobilization of lower facial wounds.

Gassner HG, Sherris DA, Friedman O.

Arch Facial Plast Surg. 2009 Mar-Apr;11(2):140-2. doi: 10.1001/archfacial.2009.3. No abstract available.

PMID:
19289689
13.

Hyperhidrosis of face and scalp: repeated successful treatment with botulinum toxin type A.

Komericki P, Ardjomand N.

Indian J Dermatol Venereol Leprol. 2012 Mar-Apr;78(2):201-2. doi: 10.4103/0378-6323.93647. No abstract available.

14.

Botulinum toxin type A in the management of a neuropathic foot ulcer.

Alsharqi A, Curley R, Winhoven S.

Clin Exp Dermatol. 2011 Dec;36(8):915-6. doi: 10.1111/j.1365-2230.2011.04098.x. Epub 2011 May 30. No abstract available.

PMID:
21623883
15.

Botulinum toxin for urogenital conditions.

Eccleston KJ, Woolley PD.

Int J STD AIDS. 2008 Dec;19(12):797-9. doi: 10.1258/ijsa.2008.008255. Review.

PMID:
19050206
16.

Successful treatment of vulvodynia with botulinum toxin A.

Tieu KD, MacGregor JL.

Arch Dermatol. 2011 Feb;147(2):251-2. doi: 10.1001/archdermatol.2010.443. No abstract available.

PMID:
21339463
17.

Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.

Gil RA, Hwynn N, Fabian T, Joseph S, Fernandez HH.

Parkinsonism Relat Disord. 2011 May;17(4):285-7. doi: 10.1016/j.parkreldis.2011.01.007. Epub 2011 Feb 5.

PMID:
21296606
18.

Efficacy of botulinum toxin type A in new daily persistent headache.

Spears RC.

J Headache Pain. 2008 Dec;9(6):405-6. doi: 10.1007/s10194-008-0078-y. Epub 2008 Oct 25. No abstract available.

19.

Botulinum toxin type A for the treatment of postamputation residual limb myokymia: a case report.

Dave SJ, Salyer J, Desai KA.

PM R. 2010 Aug;2(8):777-9. doi: 10.1016/j.pmrj.2010.03.036. No abstract available.

PMID:
20709306
20.

Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients?

Al-Khodairy AT, Gobelet C, Rossier AB.

Spinal Cord. 1998 Dec;36(12):854-8.

PMID:
9881735
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk